There are certain basic principles they teach you at business school in exchange for that six-figure price tag. The number one goal for any business is to survive. Mergers and acquisitions (M&A) generally don’t add value. And economies of scale are what help larger companies steamroll the competition. Shares of large companies generally have lower volatility which translates to lower risk. It’s one of the reasons we don’t invest in companies with a market cap of less than one billion dollars.
Another thing you’ll learn in bee school is the notion of arbitrage. Trading desks often trade the uncertainty around M&A events because sometimes things fall through. That’s why we’ve always been puzzled as to why special purpose acquisition companies (SPACs) that announce an intent to merge suddenly start appreciating well into the triple digits. The deal hasn’t even gone through, yet everyone acts as if it has. We usually like to wait for the ink to dry before taking a look at any M&A events, but today we’re going to make an exception. That’s because we’d like to take a closer look at what may soon be the biggest marijuana company in the world by revenues.
The Biggest Marijuana Stocks
We recently wrote about how the new administration views cannabis